Skip to content
Lisata Therapeutics
Lisata Therapeutics
Lisata Therapeutics
Lisata Therapeutics
Main Menu
Careers
Contact Us
Policies
Search
Active Clinical Trials
About Us
Show submenu
Overview
Management Team
Board of Directors
Pipeline
Show submenu
Overview
Pancreatic Cancer & Advanced Solid Tumors
LSTA1
Solid Tumors
Tumor-Penetrating Nanocomplex (TPN) Platform™
Coronary Microvascular Dysfunction (CMD)
XOWNA®
Critical Limb Ischemia (CLI)
LSTA12 (HONEDRA® in Japan)
Diabetic Kidney Disease (DKD)
LSTA201
No-Option Refractory Disabling Angina (NORDA)
LSTA14 (OLOGO™ in the USA)
Research & Technology
Show submenu
Overview
CendR Platform™
– Targeted penetration technology to enhance drug delivery to advanced solid tumors
CD34+ Cell Technology
Publications
Investors & News
Show submenu
Overview
News & Events
Show submenu
Press Releases
Events & Presentations
Media Coverage
Financials & Filings
Show submenu
Quarterly Results
SEC Filings
Stock Information
Show submenu
Stock Quote & Chart
Historical Price Lookup
Analyst Coverage
Corporate Governance
Show submenu
Docs & Charters
Management Team
Board of Directors
Historical Information
Show submenu
Historical Press Releases
Historical SEC Filings
Investor Resources
Show submenu
Stockholder Information
Investor FAQs
Email Alerts
IR Contact
Policies & Disclosures
Patients & Families
Show submenu
Overview
Metastatic Pancreatic Cancer Symptoms & Treatment
Coronary Microvascular Dysfunction Symptoms & Treatment
Critical Limb Ischemia and Buerger’s Disease Symptoms & Treatment
Home
/
Uncategorized
Category:
Uncategorized